$克律克斯生物制药(KERX)$
Keryx Biopharmaceuticals (NASDAQ: KERX) has been selected by InvestorsObserver analysts as a stock that is a strong candidate for a new covered call today. Selling the June $14.00 call while simultaneously buying KERX stock for $13.91 will result in a new position with a break-even point around $12.66. At that price, this position has a target return of 10.6 %. This trade has 9.0 % downside protection, while still providing a 10.6 % return in 86 days as long as KERX is above $14.00 on 6/19/2015. For co